ACE2 being a key enzymatic component of the renin-angiotensin-aldosterone system (RAAS), it degrades the ANG II, a peptide with multiple actions that is known to promote cardiovascular disease (CVD), and generates the Ang-(1-7), which, in turn, antagonizes the effects of ANG II. The gene discussed is REN; the disease is cardiovascular disorder.